INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "GLP-1 NPA THERAPIES FOR MAINTAINING BODY WEIGHT LOSS OR REDUCED HBA1C LEVELS FOLLOWING A PRIOR GLP-1 RA TREATMENT"

GENEVA, Dec. 24 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/033267) for "GLP-1 NPA THERAPIES FOR MAINTAINING BODY WEIGHT LOSS OR REDUCED HBA1C LEVELS FOLLOWING A PRIOR GLP-1 RA TREATMENT" on Jun 12, 2025. With publication no. WO/2025/259825, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROUWERS, Bram (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), GALPERIN, Vadim Michael (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Ind...